Editors’ Picks: Highlights from AACR Journals
Highlights of December 2023 AACR journals include clinical trial results, strategies to improve therapy, and a new cervical cancer...
Highlights of December 2023 AACR journals include clinical trial results, strategies to improve therapy, and a new cervical cancer...
Researchers focus on assessing quality of life and toxicity risks in people with breast cancer in a session at...
Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
As you prepare for trick-or-treating, check out the articles selected by the editors of the 10 AACR journals for...
Neuroblastoma, a rare cancer that occurs primarily in children, is a scientific paradox, said pediatric oncologist John M. Maris,...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
Forum for patient advocates explores how researchers are working to develop cancer treatments in a quicker, more efficient manner.
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected...
Courtney Addison is eternally grateful for the CAR T-cell therapy that sent her son Cayden’s leukemia into remission. But...